Tango Therapeutics (TNGX) Invested Capital (2020 - 2025)
Historic Invested Capital for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $160.0 million.
- Tango Therapeutics' Invested Capital fell 3016.93% to $160.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.0 million, marking a year-over-year decrease of 3016.93%. This contributed to the annual value of $199.5 million for FY2024, which is 2117.32% down from last year.
- As of Q3 2025, Tango Therapeutics' Invested Capital stood at $160.0 million, which was down 3016.93% from $135.0 million recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' Invested Capital ranged from a high of $365.4 million in Q3 2021 and a low of $5.0 million during Q1 2021
- Its 5-year average for Invested Capital is $222.9 million, with a median of $247.7 million in 2024.
- Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 2028489.89% in 2021, then crashed by 4551.12% in 2025.
- Tango Therapeutics' Invested Capital (Quarter) stood at $344.7 million in 2021, then dropped by 27.64% to $249.5 million in 2022, then grew by 1.46% to $253.1 million in 2023, then dropped by 21.17% to $199.5 million in 2024, then decreased by 19.79% to $160.0 million in 2025.
- Its last three reported values are $160.0 million in Q3 2025, $135.0 million for Q2 2025, and $166.8 million during Q1 2025.